Exxon Mobil Corporation (XOM)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 29,160.00 |
|---|---|
| 52-week range | 15,000.00 – 29,620.00 |
| Return, 1 month / 3 months | +15.0% / +20.2% |
| Return, 1 year / 3 years | +58.0% / +27.3% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 288.04M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Exxon Mobil Corporation is an integrated energy company that explores for and produces crude oil and natural gas, and refines fuels and lubricants that it sells through service stations and to industrial customers. Its chemical business makes petrochemical products, including plastics and specialty chemicals, used by manufacturers. The company also trades energy commodities. It is based in the United States and operates oil, gas and chemical facilities in many countries around the world.
On this site Exxon Mobil Corporation appears as a stock on the Buenos Aires Exchange (Argentina), code XOM, with prices in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Exxon Mobil Corporation (XOM) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 29,160.00 on 22 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 7 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.0% and over the last three months it rose 20.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.7% | ||
| From 52-week high | 0.0% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 20.2% | ||
| 6-month return | 32.5% | ||
| 12-month return, skipping the last month | 37.5% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 288.04M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.5% |
|---|---|
| 1 month | +15.0% |
| 3 months | +20.2% |
| 6 months | +32.5% |
| 1 year | +58.0% |
| 3 years | +27.3% |
| 5 years | +1,049.6% |
Signals
| 50-day / 200-day average | 26,434.40 / 23,389.64 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 741.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Nov 2019 | USD 0.1740 |
| 12 Aug 2019 | USD 0.1740 |
| 10 May 2019 | USD 0.1740 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.